Research programme: antibacterials - PanthecoAlternative Names: Peptide-nucleic acid antibacterials research programme - Pantheco; PNA antibacterials research programme - Pantheco; Research programme: peptide-nucleic acid antibacterials - Pantheco; Research programme: PNA antibacterials - Pantheco
Latest Information Update: 26 Jun 2003
At a glance
- Originator Pantheco
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 12 Oct 2000 Preclinical development for Bacterial infections in Denmark (Unknown route)